Nothing Special   »   [go: up one dir, main page]

Simeone et al., 2013 - Google Patents

Loss of the Kv1. 1 potassium channel promotes pathologic sharp waves and high frequency oscillations in in vitro hippocampal slices

Simeone et al., 2013

View HTML
Document ID
11650890786636457826
Author
Simeone T
Simeone K
Samson K
Rho J
et al.
Publication year
Publication venue
Neurobiology of disease

External Links

Snippet

In human disease, channelopathies involving functional reduction of the delayed rectifier potassium channel α-subunit Kv1. 1–either by mutation or autoimmune inhibition–result in temporal lobe epilepsy. Kv1. 1 is prominently expressed in the axons of the hippocampal tri …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
    • A61B5/0476—Electroencephalography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications

Similar Documents

Publication Publication Date Title
Simeone et al. Loss of the Kv1. 1 potassium channel promotes pathologic sharp waves and high frequency oscillations in in vitro hippocampal slices
Vedunova et al. Seizure-like activity in hyaluronidase-treated dissociated hippocampal cultures
Wang et al. Depolarized GABAergic signaling in subicular microcircuits mediates generalized seizure in temporal lobe epilepsy
Lozovaya et al. Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model
Avoli et al. Cellular and molecular mechanisms of epilepsy in the human brain
Muldoon et al. GABAergic inhibition shapes interictal dynamics in awake epileptic mice
Buzsáki Hippocampal sharp wave‐ripple: A cognitive biomarker for episodic memory and planning
Rinaldi et al. Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid
Verhoog et al. Mechanisms underlying the rules for associative plasticity at adult human neocortical synapses
Zhang et al. The MeCP2‐null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability
Khalilov et al. Dynamic changes from depolarizing to hyperpolarizing GABAergic actions during giant depolarizing potentials in the neonatal rat hippocampus
Wiggin et al. Episodic swimming in the larval zebrafish is generated by a spatially distributed spinal network with modular functional organization
Valeeva et al. Excitatory actions of GABA in the intact neonatal rodent hippocampus in vitro
Florez et al. In vitro recordings of human neocortical oscillations
Sgobio et al. Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment
Aivar et al. Extracellular calcium controls the expression of two different forms of ripple-like hippocampal oscillations
Neuhofer et al. Functional and structural deficits at accumbens synapses in a mouse model of Fragile X
Faria et al. Epileptiform activity and behavioral arrests in mice overexpressing the calcium channel subunit α2δ-1
Palmer et al. Diminished amygdala activation and behavioral threat response following traumatic brain injury
Tsintsadze et al. Ontogeny of kainate-induced gamma oscillations in the rat CA3 hippocampus in vitro
Grosser et al. Loss of long-term potentiation at hippocampal output synapses in experimental temporal lobe epilepsy
Weiss Chloride ion dysregulation in epileptogenic neuronal networks
Ventura-Mejía et al. Decreased fast ripples in the hippocampus of rats with spontaneous recurrent seizures treated with carbenoxolone and quinine
Cheng et al. Degraded cortical temporal processing in the valproic acid-induced rat model of autism
Ridler et al. Initiation and slow propagation of epileptiform activity from ventral to dorsal medial entorhinal cortex is constrained by an inhibitory gradient